Preview environment — 8 connected services are simulated, and anything they create is labelled. See what is live
Hormone & Longevity
Second line — by exceptionNot a controlled substanceCompounded by a 503A pharmacy

NAD+ Injection

Cellular energy cofactor

Nicotinamide adenine dinucleotide is a coenzyme central to mitochondrial energy production. Administered subcutaneously at home, or given as a slow push by our RN at our Fort Lauderdale clinic from a supply dispensed in your name.

This is not where treatment usually starts. It is prescribed when the manufactured, FDA-approved option has been ruled out for you specifically, and your nurse practitioner has to write down why before it can be sent to a pharmacy. You are welcome to ask about it — just expect the conversation.

Regulatory status

Compounded drug. Not FDA-approved. NAD+ appears in Category 1 of the FDA interim 503A bulk substances list.

Clinic infusion suite

Frequency

Weekly injection

Route

Subcutaneous or slow IV push

Supply

4-week patient-specific supply

Minimum age

21+

What it does

What patients get from this

  • Supports mitochondrial energy metabolism
  • Commonly reported gains in mental clarity
  • Pairs with sermorelin for recovery protocols
  • Available as an in-clinic slow push

We will not prescribe this if

  • Active malignancy
  • Current pregnancy or breastfeeding
  • Severe hepatic impairment

The intake asks about each of these. Some answers stop the process; others are flagged for your nurse practitioner.

Labs your NP may order

  • CMP
  • CBC

Draw at our Fort Lauderdale clinic or a reference lab near you. Your NP reviews the results and posts them to your account.

Please read

  • Compounded drugs are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
  • A 503A pharmacy may not supply a clinic with shared stock. Every in-clinic dose is filled in your name.
  • Rapid infusion commonly causes transient flushing, cramping or nausea — we push slowly for this reason.

About compounded medication

A compounded preparation is made for one named patient by a licensed pharmacy. It is not an FDA-approved product: the FDA does not review it for safety, effectiveness or manufacturing quality. Your nurse practitioner has to record a specific clinical reason why the commercially available product will not work for you before this can be prescribed — and cost on its own is not one.

A 503A pharmacy may not supply a clinic with shared stock, so your prescription is filled in your name and shipped to the clinic for you. A nurse cannot administer it without linking the order it came from.